Literature DB >> 28229372

Measuring Inhibition and Cognitive Flexibility in Friedreich Ataxia.

Louise A Corben1,2,3, Felicity Klopper4, Monique Stagnitti4, Nellie Georgiou-Karistianis4, John L Bradshaw4, Gary Rance5, Martin B Delatycki6,7,8.   

Abstract

Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder with subtle impact on cognition. Inhibitory processes and cognitive flexibility were examined in FRDA by assessing the ability to suppress a predictable verbal response. We administered the Hayling Sentence Completion Test (HSCT), the Trail Making Test, and the Stroop Test to 43 individuals with FRDA and 42 gender- and age-matched control participants. There were no significant group differences in performance on the Stroop or Trail Making Test whereas significant impairment in cognitive flexibility including the ability to predict and inhibit a pre-potent response as measured in the HSCT was evident in individuals with FRDA. These deficits did not correlate with clinical characteristics of FRDA (age of disease onset, disease duration, number of guanine-adenine-adenine repeats on the shorter or larger FXN allele, or Friedreich Ataxia Rating Scale score), suggesting that such impairment may not be related to the disease process in a straightforward way. The observed specific impairment of inhibition and predictive capacity in individuals with FRDA on the HSCT task, in the absence of impairment in associated executive functions, supports cerebellar dysfunction in conjunction with disturbance to cortico-thalamo-cerebellar connectivity, perhaps via inability to access frontal areas necessary for successful task completion.

Entities:  

Keywords:  Ataxia, Friedreich; Cerebellum; Cognitive flexibility; Inhibition (psychology); Verbal response suppression

Mesh:

Substances:

Year:  2017        PMID: 28229372     DOI: 10.1007/s12311-017-0848-7

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  48 in total

1.  The functional anatomy of inhibition processes investigated with the Hayling task.

Authors:  F Collette; M Van der Linden; G Delfiore; C Degueldre; A Luxen; E Salmon
Journal:  Neuroimage       Date:  2001-08       Impact factor: 6.556

2.  White matter changes in patients with friedreich ataxia after treatment with erythropoietin.

Authors:  Karl Egger; Christian Clemm von Hohenberg; Michael F Schocke; Charles R G Guttmann; Demian Wassermann; Marlene C Wigand; Wolfgang Nachbauer; Christian Kremser; Brigitte Sturm; Barbara Scheiber-Mojdehkar; Marek Kubicki; Martha E Shenton; Sylvia Boesch
Journal:  J Neuroimaging       Date:  2013-09-09       Impact factor: 2.486

3.  Decreased functional brain activation in Friedreich ataxia using the Simon effect task.

Authors:  N Georgiou-Karistianis; H Akhlaghi; L A Corben; M B Delatycki; E Storey; J L Bradshaw; G F Egan
Journal:  Brain Cogn       Date:  2012-04-28       Impact factor: 2.310

4.  Cognition in Friedreich ataxia.

Authors:  Antonieta Nieto; Rut Correia; Erika de Nóbrega; Fernando Montón; Stephany Hess; Jose Barroso
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

5.  Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction.

Authors:  Louise A Corben; Martin B Delatycki; John L Bradshaw; Malcolm K Horne; Michael C Fahey; Andrew J Churchyard; Nellie Georgiou-Karistianis
Journal:  J Neurol       Date:  2009-12-03       Impact factor: 4.849

Review 6.  Friedreich ataxia: the clinical picture.

Authors:  Massimo Pandolfo
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

Review 7.  Cerebellar contributions to motor control and language comprehension: searching for common computational principles.

Authors:  Torgeir Moberget; Richard B Ivry
Journal:  Ann N Y Acad Sci       Date:  2016-04       Impact factor: 5.691

8.  Differential impairment in semantic, phonemic, and action fluency performance in Friedreich's ataxia: possible evidence of prefrontal dysfunction.

Authors:  Erika de Nóbrega; Antonieta Nieto; José Barroso; Fernando Montón
Journal:  J Int Neuropsychol Soc       Date:  2007-11       Impact factor: 2.892

9.  Brain structural damage in Friedreich's ataxia.

Authors:  R Della Nave; A Ginestroni; M Giannelli; C Tessa; E Salvatore; F Salvi; M T Dotti; G De Michele; S Piacentini; M Mascalchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-18       Impact factor: 10.154

10.  Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes.

Authors:  M Cossée; A Dürr; M Schmitt; N Dahl; P Trouillas; P Allinson; M Kostrzewa; A Nivelon-Chevallier; K H Gustavson; A Kohlschütter; U Müller; J L Mandel; A Brice; M Koenig; F Cavalcanti; A Tammaro; G De Michele; A Filla; S Cocozza; M Labuda; L Montermini; J Poirier; M Pandolfo
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

View more
  4 in total

1.  Health-related quality of life and depressive symptoms in Friedreich ataxia.

Authors:  Javier Pérez-Flores; Atteneri Hernández-Torres; Fernando Montón; Antonieta Nieto
Journal:  Qual Life Res       Date:  2019-09-28       Impact factor: 4.147

2.  Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich's Ataxia Neural Stem Cells.

Authors:  Piergiorgio La Rosa; Marta Russo; Jessica D'Amico; Sara Petrillo; Katia Aquilano; Daniele Lettieri-Barbato; Riccardo Turchi; Enrico S Bertini; Fiorella Piemonte
Journal:  Front Cell Neurosci       Date:  2019-07-31       Impact factor: 5.505

3.  The cognitive profile of Friedreich ataxia: a systematic review and meta-analysis.

Authors:  Gilles Naeije; Jörg B Schulz; Louise A Corben
Journal:  BMC Neurol       Date:  2022-03-17       Impact factor: 2.474

4.  Cerebellar cognitive disorder parallels cerebellar motor symptoms in Friedreich ataxia.

Authors:  Gilles Naeije; Myriam Rai; Nick Allaerts; Martin Sjogard; Xavier De Tiège; Massimo Pandolfo
Journal:  Ann Clin Transl Neurol       Date:  2020-06-08       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.